Suryo Rahmanto, Aldwin <br/><br/>
FBW7 suppression leads to SOX9 stabilization and increased malignancy in medulloblastoma.  [electronic resource] 

 -  The EMBO journal  10 2016 
 - 2192-2212 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1460-2075 
<br/><br/><label>Standard No.: </label>10.15252/embj.201693889  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aniline Compounds--pharmacology<br/>Animals<br/>Benzamides<br/>Cell Cycle Proteins--genetics<br/>Cell Line, Tumor<br/>Cell Movement<br/>Chromones--pharmacology<br/>Cisplatin--pharmacology<br/>F-Box Proteins--genetics<br/>F-Box-WD Repeat-Containing Protein 7<br/>Glycogen Synthase Kinase 3--metabolism<br/>HEK293 Cells<br/>Humans<br/>Medulloblastoma--drug therapy<br/>Mice, Nude<br/>Morpholines--pharmacology<br/>Phosphatidylinositol 3-Kinases--metabolism<br/>Phosphoinositide-3 Kinase Inhibitors<br/>Protein Kinase Inhibitors--pharmacology<br/>Proto-Oncogene Proteins c-akt--antagonists & inhibitors<br/>Pyrimidines--pharmacology<br/>Pyrroles--pharmacology<br/>SOX9 Transcription Factor--genetics<br/>TOR Serine-Threonine Kinases--antagonists & inhibitors<br/>Ubiquitin-Protein Ligases--genetics<br/>Ubiquitination